Piramal Enterprises share price has zoomed 7% and is presently trading at Rs 938.3.
Meanwhile, the BSE HEALTHCARE index is at 41,166.6 (up 0.9%).
Among the top gainers in the BSE HEALTHCARE index today are Glenmark Pharma (up 4.8%) and METROPOLIS HEALTHCARE (up 4.7%).
GRANULES INDIA (down 1.6%) and AJANTA PHARMA (down 1.6%) are among the top losers today.
Over the last one year, Piramal Enterprises has moved down from Rs 1,025.1 to Rs 938.3, registering a loss of Rs 86.8 (down 8.5%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 41,166.6, registering a gain of 48.0% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 125.8%), GSK Pharma (up 105.5%) and Jubilant Pharmova (up 98.1%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 80,436.8 (up 1.7%).
The top gainers among the BSE Sensex today are Tech Mahindra (up 3.9%) and M&M (up 3.4%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.
In the meantime, NSE Nifty is at 24,539.2 (up 1.6%). Wipro and Tech Mahindra are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 80,436.8, registering a gain of 15,034.9 points (up 23.0%).
Piramal Enterprises net profit fell 64.3% YoY to Rs 1,739 million for the quarter ended June 2024, compared to a profit of Rs 4,877 million a year ago. Net sales declined 26.2% to Rs 21,228 million during the period as against Rs 28,780 million in April-June 2023.
For the year ended March 2024, Piramal Enterprises reported 116.9% decrease in net profit to Rs -16,835 million compared to net profit of Rs 99,686 million during FY23. Revenue of the company grew 12.2% to Rs 100,203 million during FY24.
The current Price to earnings ratio of Piramal Enterprises, based on rolling 12 month earnings, stands at -9.8.
Equitymaster requests your view! Post a comment on "Piramal Enterprises Gains 7%; BSE HEALTHCARE Index Up 0.9%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!